Medical specialists from Argentina tagged as investigators in clinical trials studying Respiratory Syncytial Virus Infections

Total 4 results

Carlos Zala
Seen in:
- Buenos Aires, Caba, GSK Investigational Site
Trials:
- NCT05590403 (Principal Investigator)
Conditions:
- Respiratory Syncytial Virus Infections
Nicolas Itcovici
Seen in:
- Ciudad de Buenos Aires, GSK Investigational Site
Trials:
- NCT05590403 (Principal Investigator)
- NCT06261957 (Principal Investigator)
Conditions:
- Respiratory Syncytial Virus Infections;
- Asthma
Pablo Doreski
Seen in:
- Buenos Aires, Caba, GSK Investigational Site
Trials:
- NCT05705440 (Principal Investigator)
Conditions:
- Respiratory Syncytial Virus Infections
Sebastian Nunez
Seen in:
- Buenos Aires, Ciudad Autonoma de Buenos Aires, GSK Investigational Site
- Buenos Aires, GSK Investigational Site
Trials:
- NCT05630820 (Principal Investigator)
- NCT05590403 (Principal Investigator)
- NCT06039579 (Principal Investigator)
- NCT06214052 (Principal Investigator)
Conditions:

Clinical Trials on Respiratory Syncytial Virus Infections

Sanofi Pasteur, a Sanofi Company

Active, not recruiting

Study of a Respiratory Syncytial Virus Candidate Encapsulated in a Lipid Nanoparticle Based Formulation in Adults Aged 18 to 50 Years and 60 Years and Older

Respiratory Syncytial Virus Immunization

United States, Australia, Puerto Rico
EuBiologics Co.,Ltd

Not yet recruiting

Phase I, First-In Human Study to Evaluate Safety and Tolerability of EuRSV in Healthy Adults Aged Between 19 Years and 80 Years (EuRSV)

Respiratory Syncytial Virus Infections | Respiratory Syncytial Virus (RSV)
Clover Biopharmaceuticals AUS Pty Ltd

Recruiting

First-in-human Safety and Immunogenicity Study of SCB-1019 in Healthy Adults

Respiratory Syncytial Virus Infection

Australia
Vigonvita Life Sciences

Recruiting

A Study of Deuremidevir Hydrobromide for Suspension in Chinese Infants Hospitalized With RSV

Respiratory Syncytial Virus Infection

China
AbbVie (prior sponsor, Abbott)

Completed

Surveillance of Synagis in Korean Pediatric Patients

Respiratory Syncytial Virus Infection
Sanofi Pasteur, a Sanofi Company

Recruiting

Study on a Live-attenuated Respiratory Syncytial Virus Vaccine for Assessment of Safety, Transmissibility, and Genetic Stability of the Vaccine Virus Among Close Contacts in Infants and Toddlers 6 to < 24 Months of Age in Puerto Rico (USA)

Respiratory Syncytial Virus Infection

United States, Puerto Rico
Pfizer

Completed

A Study to Learn How the Study Medicine Called Sisunatovir is Tolerated and Acts in the Bodies of Chinese Healthy Adults.

Respiratory Syncytial Virus Infection

China
Sanofi Pasteur, a Sanofi Company

Completed

Study of an Live-Attenuated Respiratory Syncytial Virus Vaccine in Infants and Toddlers (VAD00001)

Respiratory Syncytial Virus Infection

Honduras, United States, Chile
AbbVie (prior sponsor, Abbott)

Completed

Clinical Study of Palivizumab in Japanese Newborns, Infants and Young Children at the Age of 24 Months or Less With Immunocompromised Medical Conditions

Respiratory Syncytial Virus Infection

Japan
Shanghai Ark Biopharmaceutical Co., Ltd.
Ark Biosciences Pty Ltd.

Completed

Viral Inhibition in Children for Treatment of RSV (VICTOR)

RESPIRATORY SYNCYTIAL VIRUS INFECTIONS

Australia, Hong Kong, Israel, Lebanon, Malaysia, Poland, Taiwan, Turkey

Medical specialists from Argentina tagged as investigators in clinical trials studying Respiratory Syncytial Virus Infections

Clinical Trials on Respiratory Syncytial Virus Infections

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Hungary

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations